Studies have documented reductions in cortisol levels of 20-40% following DSIP administration, with normalization of the diurnal cortisol rhythm that is often disrupted in chronic stress states and sleep disorders
Reduced Duration and Severity of Illness: Regular use of the Tri-Immune Boost Injection may contribute to a decreased duration and severity of common illnesses, providing a proactive approach to health maintenance
Call us today at 678-928-9212 to schedule your new patient consultation
This study was approved by the ethics committee of the Italian Hospital of Buenos Aires, facilitated through the PRIISA platform (Computerized Registry Platform for Health Research in Buenos Aires), with registration code 4553
Will insurance lower what I pay
Recently, the FDA approved Wegovy for weight loss, which is a new formulation of the diabetes drug Ozempic (Semaglutide)